EOM Pharmaceuticals Holdings, Inc. (OTCMKTS:IMUC – Get Free Report)’s share price traded down 4% on Monday . The stock traded as low as $0.07 and last traded at $0.13. 5,203 shares were traded during mid-day trading, an increase of 69% from the average session volume of 3,072 shares. The stock had previously closed at $0.14.
EOM Pharmaceuticals Stock Down 4.0 %
The stock’s fifty day simple moving average is $0.17 and its 200-day simple moving average is $0.15.
About EOM Pharmaceuticals
Immunocellular Therapeutics, Ltd., a clinical-stage pharmaceutical company, focuses on the development of therapeutics and delivery technologies for the treatment of inflammatory conditions and ocular diseases. Its lead clinical asset is EOM613 solution, a peptide nucleic-acid solution with anti-inflammatory and pro-inflammatory effects on cytokines and chemokines for the treatment of cancer cachexia and rheumatoid arthritis.
Featured Stories
- Five stocks we like better than EOM Pharmaceuticals
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Merck: 4 No-Brainer Reasons to Buy This Dip
- 3 Dividend Kings To Consider
- Ackman Announces Major Stake in Uber: Should You Follow His Lead?
- Health Care Stocks Explained: Why You Might Want to Invest
- Wells Fargo Upgraded These 3 Stocks—Here’s Why They Stand Out
Receive News & Ratings for EOM Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for EOM Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
